Intuitive Surgical

Intuitive Surgical is a global technology leader in robotic-assisted minimally invasive surgery, primarily through its da Vinci Surgical System platform. The da Vinci systems are installed in thousands of hospitals worldwide and are used across urology, gynecology, general surgery, thoracic, cardiac, and head-and-neck procedures. The company also markets the Ion endoluminal system for robotic-assisted bronchoscopy and the SP (single-port) da Vinci platform. In Q2 2026, Intuitive reported adjusted EPS of $2.80 (12.9% beat) but did not raise full-year procedure-volume guidance; procedure growth was the slowest in years, and the stock hit a fresh 52-week low on the print.